Company intelligence / Profile preview

Kepler

Boston, Massachusetts, United States

Ownership: Private
Development stage: Other

Overview

Kepler Diagnostics is a medical technology company focused on developing and commercializing innovative point-of-care diagnostic solutions. The company's primary product is a rapid, quantitative test for Prostate-Specific Antigen (PSA), designed to provide immediate results in a clinical setting. By enabling real-time monitoring and screening, Kepler aims to improve patient outcomes and streamline the management of prostate health. Their technology platform is engineered for high sensitivity and ease of use, catering to the growing demand for decentralized laboratory testing.

Therapeutic areas: Oncology
Modalities: Diagnostic testPoint-of-care testing
Industry: Protein Biomarker Diagnostics

Beyond the preview

Go deeper on Kepler.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Kepler.

Explore the full profile